Lessons learned from recent hypertension trials about kidney disease.
Explore this paper's citation graph
Summary
The tenants of this article are that the baseline level of proteinuria and the magnitude ofproteinuria reduction are important determinants of renal outcome in addition to lowering BP and should be consider in all future trials.
- Type
- review
- Published
- 2006-03-01
- Cited by
- 45
- References
- 53
- OpenAlex
- https://openalex.org/W2117821921
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:27021743
Keywords
Medicine, Proteinuria, Kidney disease, Renal function, Population
References
- 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension.
- Individual and combined effects of verapamil or trandolapril on attenuating hypertensive glomerulopathic changes in the stroke-prone rat.
- Treatment of arterial hypertension in diabetic humans: importance of therapeutic selection.
- Nifedipine versus fosinopril in uninephrectomized diabetic rats.
- N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults.
- Antihypertensive Efficacy of Candesartan‐Lisinopril in Combination vs. Up‐Titration of Lisinopril: The AMAZE Trials
- Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension: a randomized controlled trial.
- Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community.
- 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)
- Effects of blood pressure level on progression of diabetic nephropathy: results from the RENAAL study.
- Class differences in the effects of calcium channel blockers in the rat remnant kidney model.
- Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: lessons from RENAAL.
- Clinical importance of microalbuminuria in diabetes and hypertension
- Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes.
- Proteinuria and other markers of chronic kidney disease: a position statement of the national kidney foundation (NKF) and the national institute of diabetes and digestive and kidney diseases (NIDDK).
- Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization.
- Effects of Combination Treatment with Losartan and Trandolapril on Office and Ambulatory Blood Pressures in Non-Diabetic Renal Disease: A COOPERATE-ABP Substudy
- The Effect of a Lower Target Blood Pressure on the Progression of Kidney Disease: Long-Term Follow-up of the Modification of Diet in Renal Disease Study
- Blood-pressure control for renoprotection in patients with non-diabetic chronic renal disease (REIN-2): multicentre, randomised controlled trial.
- C-Reactive Protein Modifies the Relationship Between Blood Pressure and Microalbuminuria
Cited by
- Effect of simvastatin on kidney function loss in patients with coronary heart disease: findings from the Scandinavian Simvastatin Survival Study (4S).
- The renoprotective effect of foods high in omega-3 fatty acids in a rat model of type 1 diabetes
- Studies of mortality risk predictors in hypertensive patients
- Management of hypertension in chronic kidney disease
- Blood pressure in renal disease: how to accomplish the goal?
- Very low protein diet supplemented with ketoanalogs improves blood pressure control in chronic kidney disease.
- Combination of antihypertensive therapy in the elderly, multicenter investigation (CAMUI) trial: results after 1 year
- Prehypertension: is it relevant for nephrologists?
- Combination of antihypertensive therapy in the elderly, multicenter investigation (CAMUI) trial.
- Does Evidence Support ReninAngiotensin System Blockade for Slowing Nephropathy Progression in Elderly Persons?
- The spectrum of albuminuria as a predictor of cardiorenal outcomes
- The impact of CKD identification in large countries: the burden of illness.
- Antiproteinuric response to dual blockade of the renin-angiotensin system in primary glomerulonephritis: meta-analysis and metaregression.
- Novel therapies of diabetic nephropathy
- Should proteinuria reduction be the criterion for antihypertensive drug selection for patients with kidney disease?
- Effects of age on hypertensive status in patients with chronic kidney disease
- Effects of angiotensin II receptor blockers on diabetic nephropathy
- Effect of angiotensin receptor blockers on cardiovascular events in patients undergoing hemodialysis: an open-label randomized controlled trial.
- Electroacupuncture and Moxibustion Attenuate the Progression of Renal Disease in 5/6 Nephrectomized Rats
- Changing the timing of antihypertensive therapy to reduce nocturnal blood pressure in CKD: an 8-week uncontrolled trial.
Related papers
- A Clinical Analysis of Proteinuria in 376 Patients with Subtertian Malaria
- Time to Recovery from Proteinuria in Patients with Lupus Nephritis Receiving Standard Treatment
- 349P Proteinuria in patients treated with ramcirumab increases the risk of renal dysfunction
- Proteinuria in essential hypertension.
- The prognostic importance of severity and type of post‐transplant proteinuria
- The relationship between aurothioglucose- and D-penicillamine-induced proteinuria.
- Pattern of proteinuria in IgA nephritis by SDS-PAGE: clinical significance.
- A Study of Estimated Glomerular Filtration Rate In Chronic Kidney Disease
- Surgically induced chronic kidney disease may be associated with a lower risk of progression and mortality than medical chronic kidney disease.
- Chronic kidney disease staging in nursing home and community older adults: does the choice of cockcroft-gault, modification of diet in renal disease study, or the chronic kidney disease epidemiology collaboration initiative equations matter?